[07-13-2010] The U.S. Food and Drug Administration (FDA) is adding information on severe liver injury to the Boxed Warning of Arava (leflunomide) - a drug used to treat rheumatoid arthritis - to ...

Rockville, MD - The disease-modifying antirheumatic drug leflunomide (Arava, Aventis) is associated with peripheral neuropathy in some patients, say FDA researchers who reviewed 80 case reports ...

Patients with rheumatoid arthritis (RA) treated with leflunomide (Arava) experienced modest but significant weight loss not seen with other RA therapies, a large Veterans Administration study found.

Like all DMARDs, leflunomide slows down how active your condition is, rather than just treating the symptoms. Leflunomide Arava is a drug approved to treat adult moderate to severe rheumatoid ...

Please provide your email address to receive an email when new articles are posted on . Sanofi announced it has released an authorized generic version of Arava for ...

Please provide your email address to receive an email when new articles are posted on . In patients with RA not responding to methotrexate, beginning with a biosimilar DMARD was cost-effective vs. a ...

Pregnant female patients with rheumatoid arthritis (RA) treated with methotrexate and leflunomide within 3 months of conception faced an increased possibility of adverse pregnancy outcomes, ...

Adults with active rheumatoid arthritis have a new generic treatment available. The Food and Drug Administration has given Lupin the green light for leflunomide tablets in dosage strengths of 10 mg ...

"We believe that prescribing this combination in routine practice is viable when combined with shared decision-making and strict monitoring of side effects," write Michelle L. M. Mulder, MD, of the ...